<p>Immunodeficient NOD/SCID mice were s.c. injected with human melanoma cells of the SK-MEL-37 cell line, and treated by weekly i.v. injections with PBS alone, IL-27 (1 µg), poly(I:C) (30 µg), or IL-27 (1 µg) plus poly(I:C) (30 µg) from 1 week postengraftment. Tumor growth was monitored weekly and expressed as volume (mm<sup>3</sup>). Data are shown as means ± SD. * indicates <i>p</i> < 0.05, compared with PBS. Similar results were obtained in two independent experiments.</p
<p>Mice were injected with PBS or Poly I:C every two days for the 28 day course. (A) Changes in body...
<p>Levels of (A) IL-5, (B) IL-12, (C) MCP-1, (D) KC, (E) MIG and (F) VEGF in BALB/c mice treated dur...
C57BL/6 (WT) and PLT2 mice were challenged with B16 tumor cells and treated with peri-tumoral inject...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng/m...
<p>(A-C) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng...
<div><p>Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antit...
Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antitumor act...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (10 ng/ml) for...
<p>(A, left panel) 1×10<sup>6</sup> B16 tumor cells were injected subcutaneously into C57BL/6 mice, ...
Polyinosinic-polycytidylic acid (poly I:C), a TLR3 ligand, is currently being tested in human clinic...
<p>IL-27 induces IRF-1 expression through WSX-1/STAT1 signaling, resulting in up-regulation of TRAIL...
Prior exposure of C-57 black mice to B-16 malignant melanoma inhibits the growth of subsequent B-16 ...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Prior exposure of C-57 black mice to B-16 malignant melanoma inhibits the growth of subsequent B-16 ...
<p>Mice were injected with PBS or Poly I:C every two days for the 28 day course. (A) Changes in body...
<p>Levels of (A) IL-5, (B) IL-12, (C) MCP-1, (D) KC, (E) MIG and (F) VEGF in BALB/c mice treated dur...
C57BL/6 (WT) and PLT2 mice were challenged with B16 tumor cells and treated with peri-tumoral inject...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng/m...
<p>(A-C) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng...
<div><p>Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antit...
Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antitumor act...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (10 ng/ml) for...
<p>(A, left panel) 1×10<sup>6</sup> B16 tumor cells were injected subcutaneously into C57BL/6 mice, ...
Polyinosinic-polycytidylic acid (poly I:C), a TLR3 ligand, is currently being tested in human clinic...
<p>IL-27 induces IRF-1 expression through WSX-1/STAT1 signaling, resulting in up-regulation of TRAIL...
Prior exposure of C-57 black mice to B-16 malignant melanoma inhibits the growth of subsequent B-16 ...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Prior exposure of C-57 black mice to B-16 malignant melanoma inhibits the growth of subsequent B-16 ...
<p>Mice were injected with PBS or Poly I:C every two days for the 28 day course. (A) Changes in body...
<p>Levels of (A) IL-5, (B) IL-12, (C) MCP-1, (D) KC, (E) MIG and (F) VEGF in BALB/c mice treated dur...
C57BL/6 (WT) and PLT2 mice were challenged with B16 tumor cells and treated with peri-tumoral inject...